Related Experiment Video

Updated: Aug 14, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Genetically modified tumor cell vaccines

F S Hodi1, G Dranoff

  • 1Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Surgical Oncology Clinics of North America
|June 13, 1998
PubMed

Insights

Advancements in tumor antigen identification and host-tumor interactions are driving cancer vaccine development. Gene transfer technologies are central to these novel immunization strategies, with ongoing research exploring genetically modified tumor vaccines.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Recent progress in identifying tumor antigens has advanced cancer vaccine research.
  • Understanding the host-tumor relationship is crucial for effective cancer immunotherapy.

Purpose of the Study:

  • To review key principles and controversies in genetically modified tumor vaccine development.
  • To explore future directions for cancer vaccine research.

Main Methods:

  • Review of recent advancements in tumor antigen identification.
  • Analysis of gene transfer technologies in cancer vaccine design.
  • Discussion of experimental findings with genetically modified tumor vaccines.

Main Results:

  • Gene transfer technologies are integral to novel cancer vaccine designs.
  • Significant progress has been made in understanding host-tumor interactions.
  • Key principles and controversies surrounding genetically modified tumor vaccines have been highlighted.

Conclusions:

  • The field of cancer vaccines is rapidly expanding due to progress in antigen identification and host-tumor relationship understanding.
  • Genetically modified tumor vaccines represent a promising area of research.
  • Future research should focus on addressing key principles and controversies in this field.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...